Translational Development Acquisition Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Public

  • Employees
  • 2

Employees

  • Stock Symbol
  • TDAC

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $10.88
  • (As of Thursday Closing)

Translational Development Acquisition General Information

Description

Translational Development Acquisition Corp is a newly organized blank check company.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 52 East 83 Road Street
  • New York, NY 10028
  • United States
+1 (917)
Primary Industry
Special Purpose Acquisition Company (SPAC)
Stock Exchange
NAS
Corporate Office
  • 52 East 83 Road Street
  • New York, NY 10028
  • United States
+1 (917)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Translational Development Acquisition Stock Performance

As of 12-Nov-2026, Translational Development Acquisition’s stock price is $10.88. Its current market cap is $210M with 19.3M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.88 $10.88 $10.41 - $10.95 $210M 19.3M 10.6K $0.26

Translational Development Acquisition Financials Summary

As of 30-Jun-2026, Translational Development Acquisition has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 206,886 229,863
Revenue 0 0 0 0
EBITDA 5,536 6,362 (71) (486)
Net Income 5,536 6,362 (71) (486)
Total Assets 157,367 181,697 175,001 2
Total Debt 1,100 200 0 348
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Translational Development Acquisition Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Translational Development Acquisition‘s full profile, request access.

Request a free trial

Translational Development Acquisition Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Translational Development Acquisition Acquisitions (1)

Translational Development Acquisition’s most recent deal was a Reverse Merger with ProLogium. The deal was made on 27-May-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ProLogium 27-May-2026 Reverse Merger Electrical Equipment
To view Translational Development Acquisition’s complete acquisitions history, request access »

Translational Development Acquisition ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Diversified Financials

Industry

Rank

Percentile

Asset Management and Custody Services

Subindustry

Rank

Percentile

To view Translational Development Acquisition’s complete esg history, request access »

Translational Development Acquisition FAQs

  • When was Translational Development Acquisition founded?

    Translational Development Acquisition was founded in 2022.

  • Where is Translational Development Acquisition headquartered?

    Translational Development Acquisition is headquartered in New York, NY.

  • What is the size of Translational Development Acquisition?

    Translational Development Acquisition has 2 total employees.

  • What industry is Translational Development Acquisition in?

    Translational Development Acquisition’s primary industry is Special Purpose Acquisition Company (SPAC).

  • Is Translational Development Acquisition a private or public company?

    Translational Development Acquisition is a Public company.

  • What is Translational Development Acquisition’s stock symbol?

    The ticker symbol for Translational Development Acquisition is TDAC.

  • What is the current stock price of Translational Development Acquisition?

    As of 12-Nov-2026 the stock price of Translational Development Acquisition is $10.88.

  • What is the current market cap of Translational Development Acquisition?

    The current market capitalization of Translational Development Acquisition is $210M.

  • What is Translational Development Acquisition’s annual earnings per share (EPS)?

    Translational Development Acquisition’s EPS for 12 months was $0.26.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process